The results indicate that breast cancer cells treated with the SMRwt peptide displayed decreased function of the human chaperone protein Mortalin, significantly affecting tumor cell proliferation and reducing tumor cell invasion and migration. The gene discussed is HSPA9; the disease is breast carcinoma.